176 related articles for article (PubMed ID: 38521502)
1. Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma.
Zhang C; Wei W; Tu S; Liang B; Li C; Li Y; Luo W; Wu Y; Dai X; Wang Y; Zheng L; Hao L; Zhang C; Luo Z; Chen YG; Yan X
J Biol Chem; 2024 Apr; 300(4):107208. PubMed ID: 38521502
[TBL] [Abstract][Full Text] [Related]
2. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
Coto-Llerena M; Tosti N; Taha-Mehlitz S; Kancherla V; Paradiso V; Gallon J; Bianco G; Garofoli A; Ghosh S; Tang F; Ercan C; Christofori GM; Matter MS; Droeser RA; Zavolan M; Soysal SD; von Flüe M; Kollmar O; Terracciano LM; Ng CKY; Piscuoglio S
Hepatol Commun; 2021 Apr; 5(4):661-674. PubMed ID: 33860124
[TBL] [Abstract][Full Text] [Related]
5. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.
Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J
J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
7. FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.
Shi JY; Ma LJ; Zhang JW; Duan M; Ding ZB; Yang LX; Cao Y; Zhou J; Fan J; Zhang X; Zhao YJ; Wang XY; Gao Q
BMC Cancer; 2017 Sep; 17(1):648. PubMed ID: 28903735
[TBL] [Abstract][Full Text] [Related]
8. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
10. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
11. Cyr61/CCN1 is regulated by Wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinoma.
Li ZQ; Ding W; Sun SJ; Li J; Pan J; Zhao C; Wu WR; Si WK
PLoS One; 2012; 7(4):e35754. PubMed ID: 22540002
[TBL] [Abstract][Full Text] [Related]
12. CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
[TBL] [Abstract][Full Text] [Related]
13. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
Feng P; Wang B; Ren EC
Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
[TBL] [Abstract][Full Text] [Related]
14. KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma.
Li Y; Tu S; Zeng Y; Zhang C; Deng T; Luo W; Lian L; Chen L; Xiong X; Yan X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):485-494. PubMed ID: 32318691
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
16. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
[TBL] [Abstract][Full Text] [Related]
17. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
[TBL] [Abstract][Full Text] [Related]
18. CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma.
Qiu QC; Wang L; Jin SS; Liu GF; Liu J; Ma L; Mao RF; Ma YY; Zhao N; Chen M; Lin BY
Sci Rep; 2018 Oct; 8(1):15029. PubMed ID: 30301907
[TBL] [Abstract][Full Text] [Related]
19. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
20. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
